title: Bone status in patients with epilepsy: relationship to markers of bone remodeling.
abstract: Patients with epilepsy and treated with antiepileptic drugs (AEDs) may develop metabolic bone disease; however, the exact pathogenesis of bone loss with AEDs is still unclear. Included were 75 adults with epilepsy (mean age: 31.90 ± 5.62 years; duration of treatment with AEDs: 10.57 ± 3.55 years) and 40 matched healthy controls. Bone mineral content (BMC) and bone mineral densities (BMD) of the femoral neck and lumbar spine were measured using dual-energy X-ray absorptiometry (DEXA). Blood samples were analyzed for calcium, magnesium, phosphate, alkaline phosphatase (ALP), 25-hydroxy vitamin D (25OHD), soluble receptor activator of nuclear factor-kappa B ligand (sRANKL), osteoprotegerin (OPG), and OPG/RANKL ratio (markers of bone remodeling). Compared to controls, patients had lower BMD, BMC, Z-score, and T-score at the femoral neck and lumbar spine (all p < 0.001). Seventy-two percent and 29.33% of patients had osteoporosis of the lumbar spine and femoral neck. Patients had significantly lower serum calcium, 25(OH)D, and OPG and higher ALP, sRANKL levels, and sRANKL/OPG (all p < 0.001). Fifty-two percent of patients had hypocalcemia, 93% had hypovitaminosis D, 31% had high levels of sRANKL, and 49% had low levels of OPG. No differences were identified between DEXA and laboratory results in relation to the type, dose, or serum levels of AEDs. BMD at the femoral neck and lumbar spine were found to be correlated with the duration of illness (p = 0.043; p = 0.010), duration of treatment with AEDs (p < 0.001; p = 0.012), and serum levels of 25(OH)D (p = 0.042; p = 0.010), sRANKLs (p = 0.005; p = 0.01), and OPG (p = 0.006; p = 0.01). In linear regression analysis and after adjusting for gender, age, weight, duration, and number of AEDs, we observed an association between BMD, 25(OH)D (p = 0.04) and sRANKL (p = 0.03) concentrations. We conclude that AEDs may compromise bone health through disturbance of mineral metabolism and acceleration of bone turnover mechanisms.
authors.affiliation: Department of Neurology and Psychiatry, Assiut University Hospital , Assiut , Egypt.
authors.forename: Sherifa A
authors.initials: SA
authors.lastname: Hamed
authors.affiliation: Department of Radiology, Assiut University Hospital , Assiut , Egypt.
authors.forename: Ehab M M
authors.initials: EM
authors.lastname: Moussa
authors.affiliation: Department of Neurology and Psychiatry, Assiut University Hospital , Assiut , Egypt.
authors.forename: Ahmad H
authors.initials: AH
authors.lastname: Youssef
authors.affiliation: Department of Neurology and Psychiatry, Assiut University Hospital , Assiut , Egypt.
authors.forename: Mohammed A
authors.initials: MA
authors.lastname: Abd ElHameed
authors.affiliation: Department of Clinical Pathology, Assiut University Hospital , Assiut , Egypt.
authors.forename: Eman
authors.initials: E
authors.lastname: NasrEldin
keywords: 25OHD; antiepileptic drugs; bone mineral density; osteoprotegerin; receptor activator of nuclear factor-kappa B ligand